As of 2025-05-19, the Intrinsic Value of Algernon Pharmaceuticals Inc (AGN.CN) is -0.06 CAD. This AGN.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of Algernon Pharmaceuticals Inc is -170.14%.
Based on its market price of 0.09 CAD and our intrinsic valuation, Algernon Pharmaceuticals Inc (AGN.CN) is overvalued by 170.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -170.14% |
| P/E | (0.00) - 0.04 | 0.02 | -75.8% |
| DDM - Stable | (0.21) - 6.99 | 3.39 | 3667.3% |
| DDM - Multi | (0.28) - 7.42 | (0.58) | -746.2% |
| Market Cap (mil) | 2.58 |
| Beta | -0.39 |
| Outstanding shares (mil) | 28.71 |
| Enterprise Value (mil) | 2.23 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.06% |
| Cost of Debt | 5.00% |
| WACC | 4.87% |